KeyCorp Predicts Reduced Earnings for Ardent Health Partners

Ardent Health Partners, LLC (NYSE:ARDT) – Stock analysts at KeyCorp reduced their FY2024 earnings estimates for Ardent Health Partners in a research note issued to investors on Monday, January 6th. KeyCorp analyst M. Gillmor now expects that the company will earn $1.20 per share for the year, down from their prior estimate of $1.28. KeyCorp currently has a “Strong-Buy” rating on the stock. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. KeyCorp also issued estimates for Ardent Health Partners’ Q4 2024 earnings at $0.44 EPS, Q1 2025 earnings at $0.55 EPS, Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.43 EPS, Q4 2025 earnings at $0.54 EPS, FY2025 earnings at $2.05 EPS and FY2026 earnings at $2.27 EPS.

ARDT has been the topic of a number of other reports. Leerink Partners raised their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $23.00 target price on shares of Ardent Health Partners in a research note on Thursday, November 14th. Stephens reaffirmed an “overweight” rating and issued a $24.00 target price on shares of Ardent Health Partners in a research note on Thursday, September 19th. Truist Financial lowered their target price on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Bank of America downgraded shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and lowered their target price for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $22.00.

Ardent Health Partners Price Performance

Shares of Ardent Health Partners stock opened at $15.84 on Thursday. Ardent Health Partners has a 12-month low of $14.57 and a 12-month high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The stock has a 50-day moving average price of $16.60.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ARDT. Seven Grand Managers LLC bought a new stake in Ardent Health Partners in the third quarter valued at $2,298,000. Allspring Global Investments Holdings LLC purchased a new position in shares of Ardent Health Partners in the 3rd quarter worth about $13,119,000. Financial Management Professionals Inc. purchased a new position in Ardent Health Partners in the 3rd quarter worth about $50,000. Charles Schwab Investment Management Inc. purchased a new position in Ardent Health Partners in the 3rd quarter worth about $526,000. Finally, BNP Paribas Financial Markets purchased a new position in Ardent Health Partners in the 3rd quarter worth about $42,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.